0
Skip to Content
fara Australia
fara Australia
Home
What is FA
Who is fara
Brand Ambassadors
Our Partners
Annual Reports
News
Patient Resources
Blogs
G.E.M Club
Fundraising
Give A Day For FA
Bequests
Workplace Giving
Research Grants
Meet Our Researchers
Treatment Pipeline
Give Now
fara Australia
fara Australia
Home
What is FA
Who is fara
Brand Ambassadors
Our Partners
Annual Reports
News
Patient Resources
Blogs
G.E.M Club
Fundraising
Give A Day For FA
Bequests
Workplace Giving
Research Grants
Meet Our Researchers
Treatment Pipeline
Give Now
Home
What is FA
Folder: About Us
Back
Who is fara
Brand Ambassadors
Our Partners
Annual Reports
News
Patient Resources
Blogs
Folder: Donating
Back
G.E.M Club
Fundraising
Give A Day For FA
Bequests
Workplace Giving
Folder: Research
Back
Research Grants
Meet Our Researchers
Treatment Pipeline
Give Now

Lexeo Therapeutics Regulatory Update and Registrational Trial Design for LX2006

19 June
Written by Victoria Rogan
Image 18-6-2026 at 3.49 pm.png
Image 18-6-2026 at 3.50 pm.png
Victoria Rogan
Previous
Previous

Biogen Community Statement
Next
Next

Design Therapeutics RESTORE-FA Trial Update

FRIEDREICH ATAXIA RESEARCH ASSOCIATION, PO BOX 210, ELSTERNWICK, VIC 3185, AUSTRALIA INFO@FARA.ORG.AU

Copyright © 2021 FARA. All Rights Reserved.

fara Australia acknowledges the Boonwurrung people of the Kulin nation as the Traditional Owners and Custodians of the land on which fara Australia’s head office resides. We pay our respects to their Elders past, present and emerging, and celebrate the stories, culture and traditions of Aboriginal and Torres Strait Islander Elders of all communities, who also work and live on this land.